These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 3540828)

  • 21. Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line.
    Nakamura H; Yoshimura K; McElvaney NG; Crystal RG
    J Clin Invest; 1992 May; 89(5):1478-84. PubMed ID: 1569186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human neutrophil elastase and elastase/alpha 1-antiprotease complex in cystic fibrosis. Comparison with interstitial lung disease and evaluation of the effect of intravenously administered antibiotic therapy.
    Meyer KC; Lewandoski JR; Zimmerman JJ; Nunley D; Calhoun WJ; Dopico GA
    Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):580-5. PubMed ID: 1892298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of C5a by phagocytic cells.
    Huber-Lang M; Younkin EM; Sarma JV; Riedemann N; McGuire SR; Lu KT; Kunkel R; Younger JG; Zetoune FS; Ward PA
    Am J Pathol; 2002 Nov; 161(5):1849-59. PubMed ID: 12414531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Granulocyte neutral proteases and Pseudomonas elastase as possible causes of airway damage in patients with cystic fibrosis.
    Suter S; Schaad UB; Roux L; Nydegger UE; Waldvogel FA
    J Infect Dis; 1984 Apr; 149(4):523-31. PubMed ID: 6427360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inactivation of chemotactic factor inactivator by cigarette smoke. A potential mechanism of modulating neutrophil recruitment to the lung.
    Robbins RA; Gossman GL; Nelson KJ; Koyama S; Thompson AB; Rennard SI
    Am Rev Respir Dis; 1990 Oct; 142(4):763-8. PubMed ID: 2221580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of C5a in the absence of C3: a new complement activation pathway.
    Huber-Lang M; Sarma JV; Zetoune FS; Rittirsch D; Neff TA; McGuire SR; Lambris JD; Warner RL; Flierl MA; Hoesel LM; Gebhard F; Younger JG; Drouin SM; Wetsel RA; Ward PA
    Nat Med; 2006 Jun; 12(6):682-7. PubMed ID: 16715088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complement-induced expression of cryptic receptors on the neutrophil surface: a mechanism for regulation of acute inflammation in trauma.
    Solomkin JS; Cotta LA; Ogle JD; Brodt JK; Ogle CK; Satoh PS; Hurst JM; Alexander JW
    Surgery; 1984 Aug; 96(2):336-44. PubMed ID: 6087484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complement Effectors of Inflammation in Cystic Fibrosis Lung Fluid Correlate with Clinical Measures of Disease.
    Sass LA; Hair PS; Perkins AM; Shah TA; Krishna NK; Cunnion KM
    PLoS One; 2015; 10(12):e0144723. PubMed ID: 26642048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of endotoxin-induced C5-derived chemotactic activity in aqueous humor.
    Rosenbaum JT; Wong K; Perez HD; Raymond W; Howes EL
    Invest Ophthalmol Vis Sci; 1984 Oct; 25(10):1184-91. PubMed ID: 6384121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. alpha 1-Proteinase inhibitor, elastase activity, and lung disease severity in cystic fibrosis.
    O'Connor CM; Gaffney K; Keane J; Southey A; Byrne N; O'Mahoney S; Fitzgerald MX
    Am Rev Respir Dis; 1993 Dec; 148(6 Pt 1):1665-70. PubMed ID: 8256917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complement activation by Pseudomonas aeruginosa biofilms.
    Jensen ET; Kharazmi A; Garred P; Kronborg G; Fomsgaard A; Mollnes TE; Høiby N
    Microb Pathog; 1993 Nov; 15(5):377-88. PubMed ID: 8015418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cleavage of the fifth component of complement and generation of a functionally active C5b6-like complex by human leukocyte elastase.
    Vogt W
    Immunobiology; 2000 Jan; 201(3-4):470-7. PubMed ID: 10776801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complement effectors, C5a and C3a, in cystic fibrosis lung fluid correlate with disease severity.
    Hair PS; Sass LA; Vazifedan T; Shah TA; Krishna NK; Cunnion KM
    PLoS One; 2017; 12(3):e0173257. PubMed ID: 28278205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of C5a-like biological activities by the fifth component of human complement (C5) upon limited digestion with noncomplement enzymes without release of polypeptide fragments.
    Wetsel RA; Kolb WP
    J Exp Med; 1983 Jun; 157(6):2029-48. PubMed ID: 6222137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Independent regulation of human neutrophil chemotactic receptors after activation.
    Bender JG; Van Epps DE; Chenoweth DE
    J Immunol; 1987 Nov; 139(9):3028-33. PubMed ID: 2822801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The extracellular neutral cysteine proteinase of Entamoeba histolytica degrades anaphylatoxins C3a and C5a.
    Reed SL; Ember JA; Herdman DS; DiScipio RG; Hugli TE; Gigli I
    J Immunol; 1995 Jul; 155(1):266-74. PubMed ID: 7602103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of chemotactic factor inactivator in modulating alveolar macrophage-derived neutrophil chemotactic activity.
    Robbins RA; Justice JM; Rasmussen JK; Russ WD; Thomas KR; Rennard SI
    J Lab Clin Med; 1987 Feb; 109(2):164-70. PubMed ID: 3805869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of anaphylatoxins through proteolytic processing of C3 and C5 by house dust mite protease.
    Maruo K; Akaike T; Ono T; Okamoto T; Maeda H
    J Allergy Clin Immunol; 1997 Aug; 100(2):253-60. PubMed ID: 9275149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation.
    Konstan MW; Hilliard KA; Norvell TM; Berger M
    Am J Respir Crit Care Med; 1994 Aug; 150(2):448-54. PubMed ID: 8049828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of neutrophil chemotactic factors in bronchoalveolar lavage fluid of asthmatic patients.
    Teran LM; Campos MG; Begishvilli BT; Schröder JM; Djukanovic R; Shute JK; Church MK; Holgate ST; Davies DE
    Clin Exp Allergy; 1997 Apr; 27(4):396-405. PubMed ID: 9146932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.